AstraZeneca shares rise as China probe update reassures
Investors were reassured after the drugmaker said a potential fine in China would have only a minor business impact.The ...
DPA International on MSN14h
AstraZeneca's Q4 profit soars 86% driven by strong product sales
British pharmaceutical giant AstraZeneca reported on Thursday a pre-tax profit of $1.666 billion for the fourth quarter, an 86% increase from $897 million in the same quarter the previous year. This ...